Drug-induced lupus: an update

Autoimmunity Reviews
Uriel Katz, Gisele Zandman-Goddard

Abstract

To review and update drug-induced lupus (DIL) with emphasis on the characteristics of anti-TNF-induced lupus. DIL is an autoimmune phenomenon triggered by a given drug and resulting in a syndrome sharing several features of systemic lupus erythematosus (SLE). Drugs like procainamide and hydralazine have been strongly associated with the development of DIL. During the past years several cases of DIL related to biologic therapy with anti-TNF drugs were reported. From the analysis of the unusual characteristics of these cases some conclusions may be drawn: anti-TNF-induced DIL may present with classical SLE dermatologic symptoms, hypocomplementemia, an increased frequency of significant anti-dsDNA antibody titers and a decreased incidence of anti-histone antibodies, all these atypical findings in classical DIL. Anti-TNF-induced DIL may be a unique form of the disease or may possibly result from the unmasking of latent idiopathic SLE.

References

Aug 1, 1979·Annals of Internal Medicine·M H ZarrabiA O Varma
Nov 16, 2001·Rheumatology·G S BleuminkB H Stricker
Aug 7, 2004·Annals of the Rheumatic Diseases·C ErikssonS Rantapää-Dahlqvist
May 19, 2005·Arthritis Research & Therapy·Michel De BandtUNKNOWN Club Rhumatismes et Inflammation
Dec 14, 2005·Current Opinion in Rheumatology·Boulos Haraoui, Edward Keystone
Dec 24, 2005·Autoimmunity·Piercarlo Sarzi-PuttiniAndrea Doria
Jul 17, 2007·Medicine·Manuel Ramos-CasalsMunther A Khamashta
Nov 6, 2007·Seminars in Arthritis and Rheumatism·Michelle F CostaBernard Zimmermann
May 20, 2008·Autoimmunity Reviews·Ying Zhou, Qianjin Lu
Jul 9, 2008·Autoimmunity Reviews·José A Gómez-PuertaRicard Cervera
Aug 30, 2008·Autoimmunity Reviews·David Fernandez, Andras Perl
Aug 30, 2008·Autoimmunity Reviews·Gabriela Gorelik, Bruce Richardson
Nov 26, 2008·Best Practice & Research. Clinical Rheumatology·Manuel Ramos-CasalsMunther A Khamashta
May 7, 2009·Rheumatology·Emma L WilliamsChristopher J Edwards
Sep 19, 2009·Lupus·A V MarzanoC Crosti
Oct 27, 2009·Autoimmunity Reviews·Manuel Ramos-CasalsUNKNOWN BIOGEAS Study Group
Dec 18, 2009·Journal of Autoimmunity·Christopher Chang, M Eric Gershwin
May 4, 2010·Autoimmunity Reviews·Charalampos PapagorasAlexandros A Drosos

❮ Previous
Next ❯

Citations

Mar 12, 2011·Clinical Reviews in Allergy & Immunology·Gisele Zandman-GoddardYehuda Shoenfeld
Apr 11, 2013·Immunologic Research·Viviana LoraGiampiero Girolomoni
Jul 27, 2011·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Laurie S DavisChandra Mohan
Apr 6, 2013·BMC Medicine·Ziv RosmanGisele Zandman-Goddard
Dec 2, 2011·Journal of Medical Case Reports·Vanja Varenika, Paul D Blanc
Sep 2, 2011·Internal Medicine·Daisuke ArakiMitsuhiro Kawano
Jan 25, 2014·Journal of Autoimmunity·Xiao Xiao, Christopher Chang
Nov 19, 2011·Clinical Reviews in Allergy & Immunology·Matthew F CusickRobert S Fujinami
Nov 19, 2013·Respiratory Investigation·Keishi KuboUNKNOWN Japanese Respiratory Society Committee for formulation of Consensus statement for the diagnosis and treatment of drug-induce
Jan 5, 2016·European Journal of Internal Medicine·Ettore Bartoli
Feb 5, 2014·Expert Review of Gastroenterology & Hepatology·Leon P McLean, Raymond K Cross
Jan 3, 2015·Expert Opinion on Drug Safety·Robert L Rubin
Jan 19, 2016·Journal of the American Academy of Dermatology·Vanessa L PascoeAlexandra Boer Kimball
Oct 19, 2011·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Petros P Sfikakis, George C Tsokos
Jun 15, 2011·Journal of Autoimmunity·Marshall BehrensVeena Taneja
May 31, 2011·Journal of Autoimmunity·Rahul SharmaShyr-Te Ju
May 31, 2011·Journal of Autoimmunity·M Eric Gershwin, Yehuda Shoenfeld
Jun 4, 2011·Journal of Autoimmunity·Erdem TüzünPremkumar Christadoss
May 5, 2011·Autoimmunity Reviews·Fabio CacciapagliaAntonella Afeltra
Feb 5, 2011·Seminars in Immunology·Lars RönnblomMaija-Leena Eloranta
Sep 25, 2010·Autoimmunity Reviews·P L Meroni, Y Shoenfeld
Jan 27, 2012·The Journal of Clinical Hypertension·Joel Handler
Nov 5, 2011·International Wound Journal·Shadi FarsaeiEffat Sadat Farboud
May 7, 2014·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Federico BardazziRiccardo Balestri
Jul 7, 2015·International Journal of Dermatology·Virendra N SehgalAnanta Khurana
Dec 31, 2014·Medicina clínica·Gonzalo Blasco-MorenteJesús Tercedor-Sánchez
Apr 25, 2015·Nature Reviews. Rheumatology·Yohei Kirino, Elaine F Remmers
Mar 17, 2015·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Manoj ThangamIgor D Gregoric
Apr 7, 2012·Autoimmune Diseases·Carlos A Cañas, Felipe Cañas
Oct 27, 2016·Autoimmunity Reviews·Michael Sticherling
Nov 9, 2011·Lupus·G Zandman-GoddardY Shoenfeld
Oct 30, 2016·Postgraduate Medicine·Bindu Madhavi MudduluruArun Swaminath
Apr 5, 2013·Lupus·C RosarioY Shoenfeld
Jun 23, 2012·The Journal of Clinical Endocrinology and Metabolism·Luigi MaionePhilippe Chanson
Nov 28, 2013·Nature Reviews. Rheumatology·Pier Luigi MeroniMaria Orietta Borghi
Jan 29, 2020·Journal of Clinical Pharmacy and Therapeutics·Yoshiro HoraiAtsushi Kawakami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Rheumatology
Emma L WilliamsChristopher J Edwards
Autoimmunity Reviews
Pier Luigi Meroni, Yehuda Shoenfeld
© 2021 Meta ULC. All rights reserved